pSivida announces resubmission of New Drug Application for ILUVIEN®
13 May 2011 | By pSivida Corp.
A New Drug Application for the investigational drug ILUVIEN® for the treatment of diabetic macular edema (DME) has been resubmitted...
List view / Grid view
News
FDA approves Merck’s VICTRELIS™ (boceprevir) oral hepatitis C virus (HCV) protease inhibitor
13 May 2011 | By Merck
VICTRELIS is approved for the treatment of CHC genotype 1 infection...
Achieving Quality & Process Excellence in the Pharma Industry
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
FDA licenses Sanofi Pasteur’s new influenza vaccine delivered by intradermal microinjection
10 May 2011 | By Sanofi Pasteur
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal...
Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
9 May 2011 | By AstraZeneca
New health economics data from a substudy of the PLATO trial...
Twelfth milestone payment as part of its discovery alliance with Boehringer Ingelheim received
9 May 2011 | By Evotec AG
Twelfth milestone triggers payment of EUR 2 million to Evotec...
Alkermes to merge with Elan Drug Technologies to create Alkermes plc
9 May 2011 | By Elan Drug Technologies (EDT)
Alkermes will merge with EDT in a cash and stock transaction currently valued at approximately $960 million...
Biogen Idec and Swedish Orphan Biovitrum receive opinion from EMA
9 May 2011 | By Biogen Idec
The EMA Pediatric Committee has adopted an opinion agreeing to the pediatric investigational plan...
Pfizer’s Prevnar 13® meets all study endpoints in two pivotal phase 3 trials in adults aged 50 and older
9 May 2011 | By Pfizer
Pfizer Inc. announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine...
Merck announces Hope Against Hepatitis C initiative to support fight against Hepatitis C Virus
9 May 2011 | By Merck
Aim is to increase awareness, prevention and diagnosis of HCV infection....
Cephalon presents positive results with NUVIGIL in largest shift work disorder trial ever conducted
6 May 2011 | By Cephalon Inc
Cephalon, Inc. presented positive results from a phase IV trial...
Abbott receives FDA approval to expand use of the RX ACCULINK® Carotid Stent System
6 May 2011 | By Abbott
Abbott announced that the FDA approved the RX ACCULINK® Carotid Stent System...
Novartis gains FDA approval for Afinitor®
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
Sigma® Life Science and King’s College London co-developing miRNA Target Identification Technology
5 May 2011 | By kdm communications limited
Exclusive license to develop and commercialize new technology...
Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
5 May 2011 | By The Scott Partnership
Novozymes Biopharma, unveiled its enhanced next-generation albumin technology...
